Chinook Therapeutics is now a Novartis Company! On August 11, 2023, Novartis completed its acquisition of Chinook. Follow the Novartis channel or visit www.novartis.com to stay updated on atrasentan, zigakibart and the rest of the Chinook pipeline. For more information on the acquisition, see our press release at: https://www.novartis.com/news/media-releases/novartis-completes-acquisition-chinook-therapeutics
View Top Employees from Chinook Therapeutics, Inc.Website | http://www.chinooktx.com/ |
Ticker | KDNY |
Revenue | $2 million |
Funding | $171 million |
Employees | 255 (255 on RocketReach) |
Founded | 2019 |
Phone | (510) 848-4400 |
Technologies |
JavaScript,
HTML,
Google Analytics
+42 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Drug Manufacturing & Research, Drug Discovery, Pharmaceuticals, Science and Engineering, Healthcare |
SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Chinook Therapeutics, Inc. employee's phone or email?
The Chinook Therapeutics, Inc. annual revenue was $2 million in 2024.
Tom Frohlich is the COO of Chinook Therapeutics, Inc..
255 people are employed at Chinook Therapeutics, Inc..
Chinook Therapeutics, Inc. is based in Seattle, Washington.
The NAICS codes for Chinook Therapeutics, Inc. are [325, 3254, 32541, 32].
The SIC codes for Chinook Therapeutics, Inc. are [283, 28, 2834].